AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of ras-transformed fibroblasts

Joffrey Pelletier 1 Danièle Roux 2, 1 Benoit Viollet 3 Nathalie Mazure 1, * Jacques Pouysségur 1, 4, *
* Auteur correspondant
1 IRCAN - Institut de Recherche sur le Cancer et le Vieillissement
2 LASMEA - Laboratoire des sciences et matériaux pour l'électronique et d'automatique
3 UM3 (UMR 8104 / U1016) - Institut Cochin
4 Hypoxie tumorale et métabolisme
Biologie Médicale
Abstract : AbstrAct Lactic acid generated by highly glycolytic tumours is exported by the MonoCarboxylate Transporters, MCT1 and MCT4, to maintain pHi and energy homeostasis. We report that MCT1 inhibition combined with Mct4 gene disruption severely reduced glycolysis and tumour growth without affecting ATP levels. Because of the key role of the 5'-AMP-activated protein kinase (AMPK) in energy homeostasis, we hypothesized that targeting glycolysis (MCT-blockade) in AMPK-null (Ampk-/-) cells should kill tumour cells from 'ATP crisis'. We show that Ampk-/-Ras-transformed mouse embryonic fibroblasts (MEFs) maintained ATP levels and viability when glycolysis was inhibited. In MCT-inhibited MEFs treated with OXPHOS inhibitors the ATP level and viability collapsed in both Ampk +/+ and Ampk-/-cells. We therefore propose that the intracellular acidification resulting from lactic acid sequestration mimicks AMPK by blocking mTORC1, a major component of an ATP consuming pathway, thereby preventing 'ATP crisis'. Finally we showed that genetic disruption of Mct4 and/or Ampk dramatically reduced tumourigenicity in a xenograft mouse model suggesting a crucial role for these two actors in establishment of tumours in a nutrient-deprived environment. These findings demonstrated that blockade of lactate transport is an efficient anti-cancer strategy that highlights the potential in targeting Mct4 in a context of impaired AMPK activity.
Keywords : cancer cell ATP AMPK-null cells glycolysis AMPK
Type de document :
Article dans une revue
Oncotarget, Impact journals, 2015, pp.11833-47
Liste complète des métadonnées

Littérature citée [59 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-01171368
Contributeur : Mireille Bos <>
Soumis le : vendredi 3 juillet 2015 - 14:39:35
Dernière modification le : jeudi 3 mai 2018 - 13:34:14

Fichier

3738-48614-3-PB.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

  • HAL Id : inserm-01171368, version 1
  • PUBMED : 26059436

Collections

UNICE | INSTITUT_PASCAL | UNIV-PARIS5 | PRES_CLERMONT | ACL-SVSAE | USPC | UNIV-COTEDAZUR

Citation

Joffrey Pelletier, Danièle Roux, Benoit Viollet, Nathalie Mazure, Jacques Pouysségur. AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of ras-transformed fibroblasts. Oncotarget, Impact journals, 2015, pp.11833-47. 〈inserm-01171368〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

168

Téléchargements de fichiers

168

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD